Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3271 to 3285 of 8218 results

  1. Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment (HTG753)

    Late-stage assessment (LSA) guidance on intermittent urethral catheters for chronic incomplete bladder emptying in adults.

    HealthTech guidance
    Published
    9 July 2025
    View recommendations

    Sections for HTG753

  2. Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment (HTG751)

    Late stage assessment (LSA) guidance on topical antimicrobial dressings for locally infected leg ulcers.

    HealthTech guidance
    Published
    19 June 2025
    View recommendations

    Sections for HTG751

  3. Drug-eluting stents for treating coronary artery disease: late-stage assessment (HTG747)

    Late-stage assessment (LSA) guidance on drug-eluting stents for treating coronary artery disease.

    HealthTech guidance
    Published
    6 May 2025
    View recommendations

    Sections for HTG747

  4. Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (HTG508)

    Evidence-based recommendations on lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) for detecting symptomatic atrial fibrillation using single time point testing in primary care.

    HealthTech guidance
    Published
    8 May 2019
    View recommendations

    Sections for HTG508

  5. DMD Care UK's guideline on respiratory care: NICE review (NR2)

    NICE has reviewed DMD Care UK’s guideline on respiratory care for Duchenne muscular dystrophy. We think the guideline from DMD Care UK is a useful resource that will help healthcare professionals improve care in this area

    NICE review
    Published
    17 December 2025

  6. Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment (HTG756)

    Early value assessment (EVA) guidance on digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments.

    HealthTech guidance
    Published
    24 July 2025
    View recommendations

    Sections for HTG756

  7. Faecal microbiota transplant for recurrent Clostridioides difficile infection (HTG638)

    Evidence-based recommendations on faecal microbiota transplant for recurrent Clostridioides difficile infection.

    HealthTech guidance
    Published
    31 August 2022
    View recommendations

    Sections for HTG638

  8. GreenLight XPS for treating benign prostatic hyperplasia (HTG650)

    Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia.

    HealthTech guidance
    Published
    29 November 2022
    View recommendations

    Sections for HTG650

  9. In-depth

    Home News In-depth {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"

  10. Diagnostics advisory committee

    Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.

  11. Indicator advisory committee (IAC)

    Membership details, terms of reference, future meeting dates and past meeting minutes for our indicator advisory committee.

  12. Interventional procedures advisory committee members

    Membership details, terms of reference, future meeting dates and past meeting minutes for our interventional procedures advisory committee.

  13. Medical technologies advisory committee

    Home Get involved Our committees NICE committee meetings...

  14. Quality standards advisory committee

    Membership details, terms of reference and future meeting dates for our quality standards advisory committee.

  15. Indicator advisory committee members

    Read biographies for all members of NICE's indicator advisory committee.